Boule Diagnostics AB Stock

Equities

BOUL

SE0011231158

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 11:29:43 2024-05-10 am EDT 5-day change 1st Jan Change
9.68 SEK -3.20% Intraday chart for Boule Diagnostics AB -3.20% -13.73%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 579M 53.4M Sales 2025 * 609M 56.17M Capitalization 376M 34.67M
Net income 2024 * 35M 3.23M Net income 2025 * 43M 3.97M EV / Sales 2024 * 0.73 x
Net Debt 2024 * 47.3M 4.36M Net Debt 2025 * 40.53M 3.74M EV / Sales 2025 * 0.68 x
P/E ratio 2024 *
10.6 x
P/E ratio 2025 *
8.56 x
Employees 228
Yield 2024 *
2.43%
Yield 2025 *
3.56%
Free-Float 61.67%
More Fundamentals * Assessed data
Dynamic Chart
1 day-3.20%
1 week-3.20%
Current month-4.16%
1 month+1.26%
3 months-6.20%
6 months+2.98%
Current year-13.73%
More quotes
1 week
9.32
Extreme 9.32
10.40
1 month
9.18
Extreme 9.18
10.45
Current year
9.05
Extreme 9.05
12.62
1 year
8.66
Extreme 8.66
12.62
3 years
8.66
Extreme 8.66
65.40
5 years
8.66
Extreme 8.66
79.60
10 years
8.66
Extreme 8.66
108.88
More quotes
Managers TitleAgeSince
Director of Finance/CFO - Dec. 31
Human Resources Officer - 22-09-30
Corporate Officer/Principal - 11-12-31
Members of the board TitleAgeSince
Director/Board Member 71 20-12-31
Chairman 72 20-12-31
Director/Board Member 57 13-12-31
More insiders
Date Price Change Volume
24-05-10 9.68 -3.20% 22,561
24-05-08 10 +0.20% 2,803
24-05-07 9.98 +0.40% 81,495
24-05-06 9.94 -0.60% 26,136
24-05-03 10 0.00% 13,187

Delayed Quote Nasdaq Stockholm, May 10, 2024 at 11:29 am EDT

More quotes
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
9.68 SEK
Average target price
10.9 SEK
Spread / Average Target
+12.60%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW